Search Results (286)

Pharmaceutical cold chains operate under tightly coupled compliance, operational, and sustainability requirements, yet managers still face a practical challenge when deciding which improvement initiatives should be implemented first under limited resources and uncertain expert judgment. This study develops an integrated multi-criteria decision framework to prioritize pharmaceutical cold chain improvement initiatives by combining fuzzy DEMATEL and fuzzy TOPSIS. Thirteen evaluation criteria were derived from the literature and organized into three clusters covering risk, operational performance, and sustainability, while nine implementable initiatives were evaluated by a cross-national panel of pharmaceutical cold chain experts. Fuzzy DEMATEL was used to model causal interdependencies among the criteria and to derive structurally informed weights, and fuzzy TOPSIS was then applied to rank the initiatives. The results show that monitoring reliability, handling and process compliance, deviation management capability, and traceability event quality act as the main upstream drivers in the system. In the resulting prioritization, handling procedure redesign and targeted training, followed by formal excursion management, emerged as the highest priority initiatives. Packaging qualification, monitoring governance, and interoperable event capture formed the next tier. Sensitivity analysis showed that the leading priorities remained stable under plausible weight changes, supporting the robustness of the proposed framework. This study moves beyond method combination by linking expert perceived interdependencies among pharmaceutical cold chain risk, performance, and sustainability criteria to a sequenced portfolio of implementable initiatives. It contributes a theory-informed and operationally interpretable prioritization framework while recognizing that the inferred influence structure reflects structured expert judgement rather than externally validated operational causality. Full article

The increasing demand for seafood over the years has led to an increase in by-products produced by the seafood processing sector. These by-products, which can represent up to 70% of processed products, are rich in nutrients and bioactive compounds, allowing them to be used in several sectors, such as food, packaging, cosmetics and pharmaceutics, provided that recovery occurs in an eco-friendly manner. In the present work, two lactic acid bacteria (Lactobacillus lactis and L. brevis) and the yeast Yarrowia lipolytica, which are organisms capable of producing organic acids and proteases during the fermentation process, were used separately to extract chitin from deep-water shrimp (Aristeus antennatus) by-products. The results showed that L. lactis was the most effective microorganism in removing both the mineral and protein fractions; therefore, it was chosen to optimize the chitin extraction technique, after which chitin was eventually converted into chitosan. The obtained chitosan showed a deacetylation degree (DDA%) of 82%, indicating good film-forming capacity. The developed biological technique allowed the valorization of shrimp by-products by recovering chitin and eventually chitosan, allowing us to produce biofilms that could help prolong seafood shelf life and, from a circular economy point of view, contributing further to promoting the sustainability of the production sector. Full article

The safety profile for bio-derived phenols post-oxidation and their related antioxidant/redox potential remain largely under-explored. Oxidation by fungi, in terms of environmental impacts via fungal oxidation by enzymes, remains an attractive strategy under milder conditions, since it is one route by which many naturally occurring lignocellulosic phenols are modified; thus, an immediate need still exists for characterizing the effects that these modified phenolic compounds may have. Methodology: We examined four different biomass-derived phenolics—vanillin, ferulic acid, syringaldehyde and guaiacol—that were oxidized with fungal laccase and characterized their effects on normal human lung fibroblasts and levels of cellular oxidative stress. Laccase activity was evaluated via the ABTS method and through simple observation and UV-Vis spectroscopic scanning of the phenolics in question, and compared with the untreated version of each phenolic. In addition to assessing the cytotoxic effect and oxidative stress generated by the phenols alone, an ELISA-based measurement assay was used to investigate the relative abundance of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and reduced glutathione (GSH) in the human normal lung fibroblast cell line under varying treatment regimes, complemented by phase-contrast microscopy. Scores integrating the biomarkers were analyzed via clustering, PCA, radar and Pearson correlation analyses, to discern distinct trends in antioxidant potential after laccase conversion. Observations: Each of the four tested phenolics demonstrated the presence of laccase activity, leading to substantial differences in visible appearance compared with the control and characteristic absorbance shifts at differing wavelengths from the original molecule. Cell viability dropped dramatically as phenol concentration was increased and the untreated phenolics resulted in diminished confluence and induced greater levels of oxidative damage, from guaiacol and syringaldehyde. Laccase treatment resulted in higher MTT reduction activity and improved cellular morphology compared with the corresponding untreated phenolic compounds. Untreated phenols induced the highest levels of MDA, while decreasing SOD, CAT, GPx and GSH levels. Post-oxidation with laccase, there were lower amounts of lipid peroxidation, along with improved levels of antioxidant activity compared with the control phenol. Multi-technique analyses show clear distinctness between the untreated and laccase-converted phenolic groups. Clustering with multivariate techniques separated all cell groups in line with control samples, grouping the laccase-converted treatments towards the middle and displaying an inverse relationship between MDA and the antioxidant markers. Conclusions: Laccase conversion markedly decreases the adverse effects that bio-derived phenols have on normal cell viability and induces fewer detrimental effects on the cellular redox balance. This is a critical discovery in terms of finding greener methods by which to upgrade bio-derived substances as we research these lignocellulosic phenols. By employing ELISA-based measurements along with multiple analysis techniques, we present a suitable paradigm for studying biological effects in all bio-based goods intended for pharmaceuticals, packaging materials, nutraceuticals or a host of different applications. Full article

The 4th International Electronic Conference on Processes—Sustainable Process Design, Engineering, Control and Systems Innovation (ECP 2025) was hosted online from 20 to 22 October 2025. The event presented recent process/systems-related research in the fields of chemistry, biology, pharmaceuticals, nutraceuticals, materials, energy, environment, food, and engineering. The main topics and sessions of the conference were as follows: Environmental and Green Processes; Chemical Processes and Systems; Food Process Engineering; Process Control and Monitoring; Materials Manufacturing and Sustainable Packaging; Pharmaceutical Processing and Particle Processes. Full article

Tamarindus indica L. (tamarind) is a traditionally consumed food and medicinal plant with increasing relevance in the development of functional foods and bioactive natural ingredients. While the fruit pulp has been extensively utilized in food products, other fractions, including seeds, shells, and leaves, remain comparatively underexploited despite emerging evidence of notable nutritional and phytochemical value. This review summarizes recent progress regarding the nutritional composition, phytochemical characteristics, biological activities, safety considerations, and industrial applications of different parts of tamarind. These studies indicate that tamarind is rich in carbohydrates, dietary fiber, proteins, minerals, vitamins, polysaccharides, and phenolic compounds, which are associated with anti-oxidant, antihyperglycemic, hypolipidemic, anti-microbial, anti-inflammatory, and prebiotic effects. Nevertheless, most evidence is derived from in vitro and animal studies, while human clinical data remain scarce. In addition to their biological activities, tamarind-derived materials have shown promise in food formulation, pharmaceutical excipients, packaging systems, and environmental applications. Although these advances have been achieved, several challenges remain in compositional standardization, extraction efficiency, safety assessment, and clinical validation. Therefore, future research should focus on establishing standardized methods, optimizing extraction processes, improving safety evaluation systems, and conducting rigorous clinical trials to support the sustainable utilization of tamarind resources. Overall, this review provides a comprehensive scientific basis for the value-added development and sustainable utilization of tamarind resources. Full article

This review examines Bacillus thuringiensis subsp. israelensis (Bti) as both a highly selective microbial larvicide and a biological platform for protein storage and delivery, enabled by the structural features of its prokaryotic insect larvicidal organelle (PILO). Bti remains the most widely deployed biological agent for mosquito control. Decades of operational use demonstrate substantial public health benefits and only limited, manageable ecological tradeoffs within integrated vector management programs (IVMP). Its narrow host range underlies an excellent safety record for humans and other vertebrates. Moreover, laboratory and field studies consistently show that collateral effects are minimal, context dependent, reversible, and largely restricted to closely related non-target aquatic dipterans. These attributes have established Bti as a cornerstone of environmentally sustainable IVMP worldwide. Here, we synthesize current knowledge on Bti biology, ecological selectivity, field performance, and the resistance-management properties embedded in the molecular architecture of the PILO. Finally, we assess emerging opportunities and technical constraints in repurposing the PILO as an in vivo microbial factory for packaging heterologous proteins with potential pharmaceutical and industrial applications. Full article

The growth of pistachio (Pistacia spp.) production, particularly in America, Iran, and Turkey, has resulted in the production of substantial quantities of by-products, including shells, fruit husks, leaves, resins, and tree pruning waste. Although these fractions contain a range of beneficial secondary compounds, they are rarely used. Recent advances in nanotechnology and materials engineering suggest that they can be used as inexpensive, renewable raw materials in the fields of agriculture, the food industry, cosmetics, pharmaceuticals, and environmental engineering. Pistachio by-products have been shown to exhibit antioxidant, antibacterial, antifungal, and anticorrosive properties, making them good candidates for use in active packaging systems and nanoencapsulation. They may also be valuable as fertilisers, animal feed, and composite materials. They have been found to have potential roles in industrial pollutant removal and energy storage, and as ‘green’ precursors for nanomaterials. This review summarises the current knowledge on the multifunctional applications of Pistacia spp. by-products, emphasising their importance in implementing circular economic strategies and sustainable industrial development. This study also addresses the practical application of pistachio by-products, as well as the widely appreciated nuts, within the domain of patents, thereby illustrating the prospective pathway of currently emerging solutions in the context of sustainable development. Full article

Concerns about the environmental and health impacts of plasticized poly (vinyl chloride) (PVC), from plasticizer loss to microplastic formation, have created a clear demand to find alternative packaging materials for medical and pharmaceutical use. As a possible polyolefin-based alternative, we blended polypropylene–ethylene copolymers with different ethylene content-controlled phase structures with styrene–ethylene/butylene–styrene block copolymer (SEBS), as modifier. SEBS is elastomeric and performs mechanically like a cross-linked rubber due to its unique microphase-separated morphology of hard spherical polystyrene (PS) domains dispersed in the soft elastomeric ethylene-butylene copolymer (EB) phase. Tests with injection-molded samples and cast films demonstrated promising combinations of flexibility, durability, and transparency—qualities essential for soft medical packaging like infusion pouches and blow–fill–seal bottles. For the desired level of flexibility (reflected by a flexural modulus of 150–250 MPa), blends with two random-heterophasic (RAHECO) copolymers achieved the lower limit with only 15–25 wt.-% SEBS, compared to the 37 wt.-% needed for a single-phase random copolymer (RACO). These blends also exhibited greater toughness and excellent transparency. In contrast, a standard impact copolymer (HECO), with its more crystalline matrix, required a higher modifier content of 45 wt.-% SEBS. Film morphology analysis indicated a gradual shift in disperse phase structure and orientation, leading to phase inversion at the highest SEBS content without negatively affecting transparency. Full article

Health-promoting foods are attracting growing interest as complements to pharmacological interventions, particularly when incorporated into bioactive-enriched functional foods. The date palm (Phoenix dactylifera L.) plays a key socio-economic role in arid and semi-arid regions, and is widely recognized for its high nutritional value, functional attributes, and therapeutic potential. Date fruits and their processing by-products, particularly the seeds, are a rich source of essential nutrients, dietary fiber, and diverse phytochemicals with documented antioxidant, anti-inflammatory, antidiabetic, and antimicrobial properties. This narrative review summarizes the latest evidence from experimental, preclinical, and emerging clinical studies on the nutritional composition, phytochemical profile, and biofunctional properties of dates and their derivatives, with particular emphasis on seeds as a significant processing by-product. Recent advances in their valorization for food applications, including bakery products, dairy products, beverages, meat products, confectionery, and active packaging, are critically discussed, as are their emerging uses in the pharmaceutical and related industries. Particular attention is given to their potential to improve the nutritional quality, functional performance, sensory attributes, and shelf life of food products. Overall, date fruits and their by-products are cost-effective, natural, and sustainable ingredients for developing value-added functional foods. Their efficient valorization offers promising strategies for reducing waste, implementing circular economy principles, and meeting the increasing consumer demand for healthier products. This review highlights the need for multidisciplinary research and innovation to advance sustainable by-product utilization, improve agro-industrial waste management, and expand the range of high-value applications for date fruits and seeds, thereby contributing to global food security, economic development, and improved public health. Full article

Microplastics (MPs) are emerging environmental contaminants detected not only in water, soil, and air but also in human biological samples. To date, three main exposure routes have been identified. Currently, the principal exposure routes examined in scholarly works are oral, inhalational, and dermal. This paper explores iatrogenic microplastic exposure (IME) as an underrecognized healthcare-associated source of exposure and suggests that, in certain clinical contexts involving invasive, device-mediated, or direct systemic contact, IME may be considered a possible fourth route of exposure. IME is the introduction of microplastics into the human body through medical interventions. A literature-based conceptual review was conducted focusing on the materials and additives used in pharmaceutical formulations, intravenous systems, and medical devices. Particular attention was given to polymer-based excipients and plasticizers (e.g., phthalates, PEG, triacetin) found in enteric drug coatings and infusion packaging. Findings suggest that polymer-derived particles may enter systemic circulation via intravenous fluids, implantable devices, or oral medications, especially under conditions of heat, pressure, or prolonged contact. Such materials, though deemed biocompatible, may contribute to nanoplastic load and chronic exposure risks. Vulnerable groups such as neonates, oncology patients, and ICU populations may face disproportionate exposure. This calls for re-evaluation of plastic use in medical practice, improved regulatory oversight of pharmaceutical excipients, and innovation in plastic-free biomedical materials. Integrating this route into toxicological and epidemiological frameworks will enrich our understanding of microplastic-related health risks and broaden the scope of environmental health strategies. Full article

Ensuring uninterrupted access to essential medicines in public healthcare systems is a persistent challenge with clinical, economic, and environmental implications. Oncology services are particularly vulnerable to stockouts, which compromise therapeutic continuity and increase reliance on urgent procurement with high carbon and waste footprints. This study proposes a risk-informed, data-driven framework for pharmaceutical inventory governance in a high-complexity public oncology hospital in Chile, aligning with sustainability goals and green supply chain principles. Using operational data from 2023–2024, we integrate descriptive analytics, ABC–XYZ segmentation, and a continuous-review (s, Q) policy extended through a Logistic Risk Index (LRI) that consolidates demand variability, supply performance, and clinical-economic criticality. Empirical analysis reveals strong expenditure concentration in AX/AY segments and significant misalignment between institutional and analytically derived parameters. A Monte Carlo simulation N = 1000 runs per scenario) compares baseline, adjusted, and fully risk-informed policies under stochastic demand and lead-time conditions. Results show that the risk-informed configuration reduces stockout exposure by up to 46%, improves fill rates (93.1% → 96.4%), and shortens replenishment delays, while maintaining total logistic cost stability. Critically, urgent orders decrease from 27.4 to 14.8 per year, avoiding an estimated 630 kg CO₂ emissions and 25 kg of packaging waste annually. These findings demonstrate that resilience, efficiency, and sustainability are not competing objectives but can be jointly achieved through integrated analytics and governance. The proposed approach offers a scalable blueprint for public health systems seeking to transition from reactive inventory management toward anticipatory, transparent, and sustainability-oriented decision-making, contributing to SDG 3 (health and well-being) and SDG 12 (responsible consumption and production). Full article

The research explored the automation production lines for the bottling of particulate materials in the pharmaceutical industries, covering the integrated processes of loading bottles, filling with particles, sealing, screwing on caps, quality inspection, and storage. The hardware system of the project consists of programmable logic controllers(PLCs), edge servers, motion control equipment, industrial cameras, and mechanical grippers for handling and storage. The aim of this research is to assist the manufacturing industry in transitioning from traditional production models to digital and intelligent production methods. From the perspective of core components, it analyzed and expounded the key technologies for building a digital production line; at the same time, from the perspective of data collection and processing, it clarified the role and advantages of the cloud platform. The product packaging process simulation covers loading bottles, filling with particle materials, sealing, screwing on caps, quality inspection, and storage. The production line issues production instructions and scheduling plans through the human-machine interaction interface and the cloud platform. Full article

In this work, we demonstrate a functional and previously insufficiently explored route for converting cyclic olefin copolymer (COC) TOPAS^® thin films into antibacterial hybrid materials through a combination of solvent casting, plasma activation, noble-metal sputtering, and subsequent thermal or laser treatment. While COC is already well-known as a transparent, chemically resistant material for pharmaceutical and optical applications, its coupling with post-treated noble-metal nanostructures for antibacterial functionality has not been systematically described. The main contribution of this study lies in showing that COC can serve not only as a passive packaging substrate, but also as an active platform for the formation of biologically relevant surface nanostructures. Compared with previously reported metal/polymer systems, the present work provides clear evidence that noble-metal layers on COC undergo substantial structural evolution after thermal and excimer-laser treatment, resulting in regular nanoclustered morphologies. A particularly important finding is the detection of Au particle implantation below the COC surface during sputtering, as revealed by Rutherford backscattering spectrometry, which distinguishes this system from conventional surface-only metal coatings. Furthermore, we show that laser and thermal processing do not merely reshape the deposited layer, but significantly influence the final biological response of the material. Ag-based structures showed strong bactericidal behavior against both Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus. The prepared samples were comprehensively characterized by AFM, DSC, RBS, SEM, and TGA, and their roughness and wettability were also evaluated, enabling direct correlation between physicochemical changes and antibacterial performance. These results introduce a new strategy for upgrading conventionally used pharmaceutical COC materials into multifunctional surfaces with added antibacterial value. Full article

Metal packaging materials remain fundamental across food, beverage, pharmaceutical, cosmetic, and technical sectors owing to their combination of mechanical robustness, total light and gas barrier performance, thermal resistance, and established recyclability. Aluminum alloys, tinplate, tin-free steel (TFS/ECCS), stainless steels, metal–matrix composites (MMCs), and metal–polymer or metal–paper laminates define distinct metal-based packaging architectures whose metallurgical and interfacial design governs forming behaviour, corrosion and migration pathways, coating integrity, and mechanical reliability. In this review, these architectures are examined from a materials- and systems-oriented perspective, linking composition, microstructure, processing routes, and surface engineering to functional performance across rigid, semi-rigid, and flexible formats. The analysis also considers the ongoing transition from bisphenol A (BPA)-based epoxy linings to BPA-free and hybrid coating chemistries, the use of nano-structured metallic and metal-oxide surfaces, and the role of composite laminates in which thin metallic foils are combined with polymeric or paper-based structural layers. These material and architectural aspects are discussed together with safety, regulatory, and circularity considerations that increasingly influence the design and selection of metal-based packaging. Ion migration, coating degradation, and corrosion under realistic storage environments are considered in relation to EU, FDA, ISO, and sector-specific requirements, while attention is also paid to the contrast between well-established closed-loop recycling infrastructures for aluminum and steel and the more complex end-of-life management of coated metals and multilayer laminates. The review provides a unified framework connecting materials selection, metallurgical design, processing, performance, regulatory compliance, and sustainability in metal-based packaging systems. Applications spanning consumer goods, pharmaceuticals, cosmetics, and advanced electronics are integrated to support an overall understanding of how metallic and hybrid metal-based architectures underpin functional reliability and life-cycle sustainability. Full article

Background: Fixed-dose combination drugs (FDCs) are combinations of two or more active ingredients in a single dosage form. These formulations have proven effective in combating the development of resistance in diseases such as tuberculosis and malaria. Despite the benefits observed in the aforementioned cases, fixed-dose antibiotics combinations (FDACs) are increasingly raising questions about their rationality. This is the case for several FDACs listed in the AWaRe classification as not recommended, which unfortunately remain available on the pharmaceutical market, particularly in low- and middle-income countries like the Democratic Republic of Congo (DRC). Objectives: To identify the essential medicines available in pharmacies open to the public in the city of Kinshasa and to assess their inclusion in the DRC’s National List of Essential Medicines (NLEM) and in the World Health Organization’s (WHO) List of Essential Medicines (LEM). The rationality of the FDACs circulating in the city of Kinshasa were also evaluated based on the 2023 AWaRe classification. Methods: A cross-sectional and descriptive study was conducted between February and October 2025 in Kinshasa. For this purpose, fifty registered pharmacies open to the public were selected by systematic random sampling as the research sample. Data collection consisted of completing a data collection form after we had provided the pharmacies’ owners with the necessary explanations regarding the importance of the study and guaranteed their anonymity. Results: The controlled FDACs encountered comprised 27 specialties across 15 different formulations. Out of 15 formulations, 12 (80%) were included on the WHO list of non-recommended antibiotics and were not included in the DRC’s NLEM nor in the WHO’s LEM. Some had been withdrawn from the market in their countries of manufacture. Of the 15 FDACs evaluated for their rationality and compliance, the injectable FDACs presented problems related to the relevance and completeness of information contained on their packaging. On their primary packaging, there was a significant difference in the expiration dates of the powder and sterile water for injection contained in the combination pack, ranging from 6 to 36 months. Furthermore, the secondary packaging lacked data related to the sterile water for injection contained in the combination pack. In addition, several medications contained the same therapeutic combination. For injectable FDAC, for example, the combination Ceftriaxone-Sulbactam was represented by eight medications. For oral FDACs, the combination Sulfamethoxazole-Trimethoprim was represented by seven medications. Globally, 100% of these drug combinations originated from India. Conclusions: Fifteen varieties of FDACs were available in Kinshasa, most of which (80%) were unsuitable. It is important that public health authorities address this situation and develop stricter guidelines for granting marketing authorizations, particularly for FDACs. Full article